TABLE 2.
Distribution of gB genotypes
| Specimen (n) | No. (%) of samples bearing genotype:
|
||||
|---|---|---|---|---|---|
| gB1 | gB2 | gB3 | gB4 | Mixed infection | |
| Sera (40) | 5 (12.5) | 1 (2.5) | 17 (42.5) | 1 (2.5) | 16 (40) |
| CSF (26) | 3 (11.5) | 10 (38.5) | 8 (30.8) | 2 (7.7) | 3 (11.5) |
| M-nPCR+ samplesa (66) | (12.1) | (16.7) | (37.9) | (4.5) | (28.7) |
| Outcome | |||||
| Asymptomatic patientsb (12) | 2 (16.7) | 0 (0) | 7 (58.3) | 1 (8.3) | 2 (16.7) |
| Symptomatic patientsc (47) | 3 (6.4) | 11 (23.4) | 16 (34) | 2 (4.3) | 15 (32) |
| CMV retinitis (35) | 1 (2.9) | 10 (28.6) | 11 (31.4) | 2 (5.7) | 11 (31.5) |
a
Of 70 tested samples, 66 were gB genotyped.
b
Of 16 clinical samples obtained from asymptomatic patients 4 were found to be gB M-nPCR assay negative.
c
A total of 47 clinical samples were obtained from symptomatic patients, including 35 patients diagnosed with retinitis.